✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
Our results emphasize the need of both procedures in the diagnosis and follow-up of CML patients.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:The Philadelphia chromosome (Ph) is the cytogenetic hallmark of chronic myeloid leukemia (CML), based on clinical and morphological criteria.
📊
Key Findings & Data:Both cytogenetic analysis and reverse transcriptase-PCR (RT-PCR) detection of the chirneric bcr/abl mRNAs were performed on 30 patients prediagnosed as CML.
💡
Conclusion & Impact:Our results emphasize the need of both procedures in the diagnosis and follow-up of CML patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
The Philadelphia chromosome (Ph) is the cytogenetic hallmark of chronic myeloid leukemia (CML), based on clinical and morphological criteria. Both cytogenetic analysis and reverse transcriptase-PCR (RT-PCR) detection of the chirneric bcr/abl mRNAs were performed on 30 patients prediagnosed as CML. The methodology and results of RT-PCR detection of the bcr/abl mRNA, and those of cytogenetic analysis are compared and discussed. Our results emphasize the need of both procedures in the diagnosis and follow-up of CML patients.
🔖
Cite This Article
SERCAN, H. O., ERESEN, Ç., YÜKSEL, E., SERCAN, Z., PARALI, F., ALTUNGÖZ, O., SAKIZLI, M. (1998). Molecular detection of bcr/abl m-RNA and cytogenetic analysis in CML patients: Comparison of results and factors affecting the methodologies used. Turkish Journal of Cancer, Cilt: 28 - Sayı: 4, 166–173. https://ajindex.com/articles/368437